You may also like
Baxter Initiates Worldwide Voluntary Recall Of Select Lots Of 5 percent Dextrose Injection, USP And 0.9 percent Sodium Chloride Injection, USP Intravenous (IV) Solutions
Baxter International Inc. announced today it has initiated a voluntary recall to the hospital/user level of one lot of 5 percent Dextrose Injection, USP and four lots of 0.9 percent Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver.
2 min read
Does Intraoperative Cell Salvage Reduce Postoperative Infection Rates in Cardiac Surgery?
Cell salvage was directly associated with higher infection rates, but this direct effect was almost completely eliminated by its indirect protective effect through reduced allogeneic blood transfusion.
1 min read
Effect of Nitric Oxide on Postoperative Acute Kidney Injury in Patients who Underwent Cardiopulmonary Bypass: a Systematic Review and Meta-analysis with Trial Sequential Analysis
NO appeared to reduce the risk of postoperative AKI in patients undergoing CPB.
1 min read
